Understanding the mode of binding mechanism of doripenem to human serum albumin: Spectroscopic and molecular docking approaches

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Molecular Recognition

• Publication date

  2018-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/jmr.2710PMID 29603446
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Saffron carotenoids (crocin and crocetin) binding to human serum albumin as investigated by different spectroscopic methods and molecular docking

  2018cited by this paper
• Probing the interaction of anticancer drug temsirolimus with human serum albumin: molecular docking and spectroscopic insight

  2018cited by this paper
• Structural insight into mode of binding of Meropenem to CTX-M-15 type β-lactamase.

  2017cited by this paper
• An Investigation on intermolecular interaction between Bis(indolyl)methane and HSA and BSA using multi technique methods

  2017cited by this paper
• Folic acid delivery by serum proteins: loading efficacy and protein morphology

  2017cited by this paper
• Interaction of meropenem with ‘N’ and ‘B’ isoforms of human serum albumin: a spectroscopic and molecular docking study

  2016cited by this paper
• A Mechanism of Synergistic Effect of Streptomycin and Cefotaxime on CTX-M-15 Type β-lactamase Producing Strain of E. cloacae: A First Report

  2016cited by this paper
• Spectroscopy study and co-administration effect on the interaction of mycophenolic acid and human serum albumin.

  2015cited by this paper
• An insight into the biophysical characterization of different states of cefotaxime hydrolyzing β-lactamase 15 (CTX-M-15)

  2015cited by this paper
• PubChem Substance and Compound databases

  2015cited by this paper
• Interaction of chlorogenic acids and quinides from coffee with human serum albumin.

  2015cited by this paper
• Insight into the binding mechanism of imipenem to human serum albumin by spectroscopic and computational approaches.

  2014cited by this paper
• Subdomain IB is the third major drug binding region of human serum albumin: toward the three-sites model.

  2013cited by this paper
• Insignificant β‐lactamase activity of human serum albumin: no panic to nonmicrobial‐based drug resistance

  2013cited by this paper
• Efflux-Mediated Drug Resistance in Bacteria

  2012cited by this paper
• Open Babel: An open chemical toolbox

  2011cited by this paper
• Exploring the drug-binding site Sudlow I of human serum albumin: the role of water and Trp214 in molecular recognition and ligand binding.

  2011cited by this paper
• Structural Model of the Pre-pore Ring-like Structure of Panton-Valentine Leukocidin: Providing Dimensionality to Biophysical and Mutational Data

  2010cited by this paper
• Doripenem: a new carbapenem antibiotic.

  2010cited by this paper
• AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

  2009cited by this paper
• Efflux-Mediated Drug Resistance in Bacteria

  2009cited by this paper
• AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading

  2009influential reference
• Gaining an insight into the photoreactivity of a drug in a protein environment: a case study on nalidixic acid and serum albumin.

  2008cited by this paper
• Molecular interactions between Wells-Dawson type polyoxometalates and human serum albumin.

  2008cited by this paper
• Conformation of Trimeric Envelope Glycoproteins: The CD4-dependent Membrane Fusion Mechanism of HIV-1

  2007cited by this paper
• Collective Dynamics of EcoRI-DNA Complex by Elastic Network Model and Molecular Dynamics Simulations

  2006cited by this paper
• An antibiotic resistance fighter.

  2006cited by this paper
• Effect of albumin conformation on the binding of ciprofloxacin to human serum albumin: a novel approach directly assigning binding site.

  2006cited by this paper
• The extraordinary ligand binding properties of human serum albumin

  2005cited by this paper
• Bacterial-population responses to drug-selective pressure: examination of garenoxacin's effect on Pseudomonas aeruginosa.

  2005cited by this paper
• Structural basis of the drug-binding specificity of human serum albumin.

  2005cited by this paper
• Effect of Ertapenem Protein Binding on Killing of Bacteria

  2004cited by this paper
• Interactions of human serum albumin with chlorogenic acid and ferulic acid.

  2004cited by this paper
• Impact of plasma protein binding on antimicrobial activity using time-killing curves.

  2004cited by this paper
• Atomic Force Microscopy Analysis of Intermediates in Cobalt Hexammine-Induced DNA Condensation

  2000cited by this paper
• Influence of protein binding on the pharmacodynamics of ceftazidime or ceftriaxone against gram-positive and gram-negative bacteria in an in vitro infection model.

  1998cited by this paper
• Recent advances in chromatographic and electrophoretic methods for the study of drug-protein interactions.

  1997cited by this paper
• Preliminary crystallographic studies of four crystal forms of serum albumin.

  1994cited by this paper
• Principles of frequency-domain fluorescence spectroscopy and applications to cell membranes.

  1988cited by this paper
• Protein Binding as a Primary Determinant of the Clinical Pharmacokinetic Properties of Non-Steroidal Anti-Inflammatory Drugs

  1987cited by this paper
• Study of the interaction between human serum albumin and some cephalosporins.

  1982cited by this paper
• Exposure of tryptophanyl residues in proteins. Quantitative determination by fluorescence quenching studies.

  1976cited by this paper
• Determination of the secondary structures of proteins by circular dichroism and optical rotatory dispersion.

  1972cited by this paper
• OXYGEN QUENCHING OF FLUORESCENCE IN SOLUTION: AN EXPERIMENTAL STUDY OF THE DIFFUSION PROCESS

  1962cited by this paper

• Picloram binds to the h1 and h4 helices of HSA domain IIIA at drug binding site 2.

  2023cites this paper
• Insights into Multifunctional Nanoparticle-Based Drug Delivery Systems for Glioblastoma Treatment

  2021cites this paper
• A mechanistic approach to prove the efficacy of combination therapy against New Delhi metallo-β-lactamases producing bacterial strain: a molecular and biochemical approach

  2020cites this paper
• Synergistic effect of doripenem in combination with cefoxitin and tetracycline in inhibiting NDM-1 producing bacteria.

  2019cites this paper
• Streptozocin; a GLUT2 binding drug, interacts with human serum albumin at loci h6DOM3-h7DOM3.

  2019cites this paper
• Significant role of Asn-247 and Arg-64 residues in close proximity of the active site in maintaining the catalytic function of CTX-M-15 type β-lactamase

  2019cites this paper
• Elucidating the interaction of letrozole with human serum albumin by combination of spectroscopic and molecular modeling techniques

  2018cites this paper